Wed 5 Mar 2025
Past event

No longer the forgotten service, POCT is revolutionising patient care and transforming pathways both in and outside of hospital settings

At this face-to-face networking conference in Birmingham, POCT colleagues from across the country joined the conversation, navigating their way tough questions on ensuring quality, keeping up with high demand and developing new services that are in line with national initiatives. Attendees gained inspiration from services that are delivering resilient, new POCT pathways, and took home practical ideas to drive forward their own services.

POCT National Networking Forum 2025
Past event

Bringing POCT professionals and industry together

Over 100 POCT professionals took the day out to share experiences and insights into the national strategy, quality standards and innovative pathways, at this valuable forum. This event provided the perfect opportunity and support to discover new ways of working, be motivated by other services and share challenges. Key focusses on the day included:

  • Updating your understanding on how GIRFT is working to validate new POCT devices
  • Boosting your confidence for your next UKAS inspection by learning from other services
  • Understanding what the new ISO 15189:2022 actually means for POCT from an accredited team
  • Becoming motivated by hearing about new pathways and the practicalities of how they have been implemented
  • Discovering the outcomes from a brand-new ARI pilot scheme that aims to tackle infection outside of hospitals
  • Creating a successful business plan that ensures that your service is well funded and future proofed
  • Evaluating the national picture and taking key learning from other devolved nations
  • Developing a rapid testing, 24/7 day a week service in emergency departments
  • Learning how others have tackled connectivity challenges as work diversifies into different settings

Stay abreast of advancements in POCT

This unique event also enabled the delegates to meet industry providers and learn how to strike the balance between pushing forward into the next phase whilst improving on existing processes. Further benefits included:

  • Building networks: gain access to POCT professionals and thought leaders to be a part of a wider community of peers for support, advice and guidance
  • Professional learning: discover national updates, evidenced learnings and real-world examples
  • Facilitated discussion sessions: identify innovative approaches for enhancing your pathways and improving your service delivery

"Valuable experience listening to how POCT services in other areas/countries are delivered and managed"

POCT National Networking Forum 2025, March 2025

"Excellent network event with extremely useful updates in POCT"

POCT National Networking Forum 2025, March 2025

"Very well-run day. Great talks with lots of useful information and knowledge sharing"

POCT National Networking Forum 2025, March 2025

With thanks to our sponsors

SBK would like to thank AbbottBHR Biosynex, Fujifilm, Genedrive Diagnostics Ltd and Roche for sponsoring this event.

                                

And to our exhibitors

SBK would also like to thank AB ScientificAccubio CepheidCitizen Care Health, Eurobio ScientificHORIBA UKKatalyst DiagnosticsQuidelOrthoRandoxSterilabSysmex and Una Health for exhibiting this event.

9:00
Registration, refreshments and networking opportunity
Sponsoring today is Abbott, BHR Biosynex, Fujifilm, Genedrive Diagnostics Ltd and Roche; exhibiting are QuidelOrtho, Sysmex, Sterilab, Una Health, Katalyst Diagnostics, Citizen Care Health, Cepheid, AB Scientific, HORIBA UK and Accubio. Please do take this time to visit their stands to find out more about their products and services.
9:30
Chair’s opening remarks
Dr Martin Myers MBE, Senior Clinical Advisor, Pathology at GIRFT, Consultant Clinical Biochemist and Associate Divisional Medical Director for Pathology, Lancashire Teaching Hospitals NHS Foundation Trust
National update
9:40
GIRFT Update: Data supported decision making to ensure a safe and effective future for POCT
  • Utilising the ‘Blue Book’: a validation tool to ensure data supported decision making for tests
  • Tier 1: GIRFT planning for pathology delivery in the community
  • Ensuring effective governance to enable effective, safe, POCT in the community for the future
Dr Martin Myers MBE, Senior Clinical Advisor, Pathology at GIRFT, Consultant Clinical Biochemist and Associate Divisional Medical Director for Pathology, Lancashire Teaching Hospitals NHS Foundation Trust
Enabling service transformation
10:10
Case study: Delivering an ARI Respiratory Hub in the North West
  • Developing an acute community respiration hub to keep infection out of the hospital
  • Targeting infection in the community and reducing A&E attendance
  • Sharing outcome data and demonstrating the impact of the ARI respiratory hub
Katie Moss, Programme Director, Greater Manchester Diagnostics Network and Chair of the North West Point of Care Strategy Group
10:40
Questions and answers with your speakers
10:50
OSD Healthcare: Use of POCT in Day Case Surgeries and Outpatients
Vivid Riolo, UCC and OPD Registered Nurse, POCT Lead, OSD Healthcare
11:05
Refreshments, networking break and meet the exhibitors
POCT across the UK
11:30
Wales’s National POCT Strategy: Setting up and developing point-of-care testing services
  • Assessing the impact of new POCT programmes, best practice, and quality and safety issues
  • Achievements to date: developments in quality control, standards and governance models
Annette Thomas, Consultant Clinical Biochemist, Cardiff and Vale University Health Board
11:50
POCT-for-Scot: Shared experiences of the Scottish Network
  • Opportunities and vision: creating a network to share information across health boards
  • Looking forward: potential impact of shared innovations, educational materials and networking
Jayne Mckay, Point of Care Manager, NHS Tayside and Director of POCT- for-Scot Director
12:10
Northern Ireland – A Regional Approach to POCT
  • Developing a regional strategy, building a workforce plan and enabling IT and procurement
  • Enabling new initiatives to improve governance in POCT
Dr Jenny Hamilton, Chair, Northern Ireland POCT Specialty Forum, Consultant Clinical Biochemist, Southern Health and Social Care Trust
12:30
Panel question and answers with your speakers
12:40
Refreshments, networking lunch and meet the sponsors
Achieving POCT accreditation
1:50
Interactive discussion: Ensuring quality and effective clinical governance
  • Where is your service on the journey to accreditation?
  • What are you doing to ensure effective clinical governance without CQC inspection?
  • What would effective quality monitoring look like? How do we ensure quality in our lab?
2:10
Interactive discussion feedback: Ensuring quality and effective clinical governance
2:30
Case study: Becoming an accredited service and achieving ISO15189:2022
  • Practical guidance to understand how we can incorporate the new standards
  • Taking accreditation forward: building and developing the service under new ISO standards
  • Exploring our journey to achieving accreditation for our service: what did we learn?
Katy Heaney, POCT Consultant Speciality Lead and Director, Qpoint POCT EQA schemes, Berkshire and Surrey Pathology Services
3:00
Questions and answers with your speakers
3:10
Refreshments, networking break and meet the exhibitors
3:30
Case study: Provision of POCT and rapid testing in the ED lab
  • Understanding the delivery a rapid POCT emergency department (ED) lab
  • Practical insights into changes in the patient pathway and analysing the wider benefits
  • Ensuring complete connectivity with patient files and EPR systems
Robert Bolton, Point of Care Coordinator, Lancashire Teaching Hospitals NHS Foundation Trust
4:00
Funding community diagnostics; working towards service resilience
  • Understanding our service: Greater Manchester POCT cost model
  • Our journey to date towards funding and commissioning community POCT services
  • Where are we going next? Tackling challenges in funding POCT services
Dr Sharman Harris, Consultant Biochemist and Clinical Lead for POCT, Stockport NHS Foundation Trust
4:30
Questions and answers with your speakers
4:40
Chair’s closing remarks and close of day

With thanks to the speakers


Job Title:
Senior Clinical Advisor and Consultant Clinical Biochemist and Associate Divisional Medical Director for Pathology
Organisation
Pathology at GIRFT and Lancashire Teaching Hospitals NHS Foundation Trust
Biography

Dr Myers is a consultant Clinical Biochemist, and Laboratory Director of Clinical Biochemistry at Lancashire Teaching Hospitals NHS Foundation Trust, Preston, UK. Whilst at Preston Dr Myers has introduced a continuous program of Pathology redesign, improving the clinical and operational effectiveness and productivity of pathology. During this time, he was the Associate Divisional Medical Director of Pathology for 4 years, Clinical Director of Pathology for 14 years, Lead Scientist for over 10 years; he is also the Clinical Lead for Point of Care Testing. 

Dr Myers is the Co-Clinical Lead for the NHSE Pathology Getting it Right First Time (GIRFT) Programme, which has undertaken an evidenced-based review of Pathology services in England in order to improve quality and reduce unwarranted variation.  The National Report was launched in 2022 and the GIRFT Clinical Team is now working on implementing the recommendations.  Dr Myers is a member of the National New Hospital Programme Clinical Workstream Steering Group representing Laboratory and Point of Care Testing in Pathology.  Dr Myers is also the Chair of the MHRA IVD Expert Advisory Group.

His interests include the use of automation, point of care testing and informatics in improving the quality of the diagnostic process and redesigning patient-focussed pathology delivery. He introduced the “Laboratory Anywhere” concept to ensure that diagnostics are delivered in a variety of locations both inside and outside the hospital ensuring that diagnostics are embedded in the patient pathway. He introduced a 24/7 Rapid SARS-CoV-2 testing (COVID-Net) for patients which then expanded to an Acute Respiratory Infection POCT service. This has now been expanded for Rapid multiplex GI and respiratory pathogens as well as Lab-in-Box technology to support Same Day Emergency Care, Virtual Wards, Hospitals at Home and Community Diagnostic Centres.


Job Title:
Programme Director
Organisation
Greater Manchester Diagnostics Network and Chair of the North West Point of Care Strategy Group
Biography

Katie Moss is the Greater Manchester Diagnostic Network Programme Director with over 24 years’ experience of working within various NHS diagnostic and senior management roles and is now responsible for leading and directing the portfolio of the Greater Manchester Diagnostic Network.

After graduating with a 2:1 BSc in Biomedical Science, Katie was appointed as an NHS Trainee Biomedical Scientist where she worked and specialised in Microbiology for over 14 years.  In that time, Katie went onto to complete a master’s in biomedical science and management Training Certificate before deciding upon a change of career.  Katie went on to successfully undertake roles within Clinical Audit, Transformation and Programme Management whilst developing her educational achievements with the completion of various programme management and leadership qualifications.

Katie is now an influential and highly recognised member of the NHS diagnostic community who has proven experience of delivering complex transformation programmes, establishing multi stakeholder networks including the establishment of both the Greater Manchester Imaging and Pathology Networks and developing short- and long-term strategic business models. 

Katie has a strong passion for diagnostic innovation and improving patient care through the adoption of new technologies and out of hospital diagnostics which support faster, real-time diagnosis and enable patients to have a greater ability to manage their own health and wellbeing.

Katie is the current chair of the Northwest Point of Care Strategy Group and is also responsible for leading the establishment of the Greater Manchester Physiological Sciences Network.

Outside of work, Katie is a mum to one, wife to one and dog parent to two bonkers spaniels.  She often spends her down time, walking the dogs, playing netball and being a real foodie, she loves to eat out and experience different cuisine.


Job Title:
UCC and OPD Registered Nurse, POCT Lead
Organisation
OSD Healthcare
Biography

Job Title:
Consultant Clinical Biochemist
Organisation
Cardiff and Vale University Health Board
Biography

Annette Thomas is a Consultant Clinical Biochemist at Cardiff and Vale University Health Board with over 40 years’ experience in Laboratory Medicine, over 20 years of which has been as Director of Weqas, a well-respected International EQA provider and Reference Measurement Laboratory.

Annette is also the National Point of Care (POCT) Clinical lead for Wales, a seconded position to the Wales NHS Executive responsible for delivering the strategy plan for POCT. She represents POCT on Welsh Government advisory Committees and chairs the National POCT Strategic Board and the POCT Delivery Group.

She is a member of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) Task Force on Global Lab Quality and past chair of the IFCC Committee on Analytical Quality.

She has previously held posts on the Executive Board of the European Committee for External Quality Assurance Programmes in Laboratory Medicine (EQALM), chair of the All Wales Clinical Biochemistry Audit Group and chair of the National Clinical Biochemistry and Laboratory Medicine (ACB) Audit Committee in the UK.

In 2019 she received the EQALM Adam Uldall Award for her contribution to promoting quality in laboratory medicine and the Healthcare Science Lifetime Achievement award from the Welsh Government.


Job Title:
Point of Care manager for Diagnostic Laboratories
Organisation
NHS Tayside
Biography

Jayne first qualified in November 2000 as Haematology MLSO and started her Point of Care journey with INR’s in the community. Today she is the Point of Care manager for Diagnostic Laboratories at NHS Tayside on the east coast of Scotland, a post she has held since July 2020. Her remit is to provide laboratory oversight and mitigate risk within POC schemes ensuring that results can be used confidently in effective and efficient patient management pathways. This includes schemes both within hospital environments and the community, encompassing laboratory diagnostic specialities of Haematology, Biochemistry and Virology.

She co-founded POCT – FOR – SCOT LTD which is a website / Instagram / Face book community to share learning, provide support and push for regulation and strategic developments of point of care.  

Jayne is an advocate for ensuring Point of Care is used in the correct environment with innovative and effective patient management pathways that allow the right result to be used for positive patient gain. She champion’s this throughout her trust and the wider Scottish network.

Jayne currently sits of the specialist advisory panel for point of care at the IBMS and is part of a short life working group in Scotland advocating for point of care with strong policies and strategic goals to support the frail infrastructure of a NHS requiring innovation to survive the future.


Job Title:
Chair and Consultant Clinical Biochemist
Organisation
Northern Ireland POCT Specialty Forum and Southern Health and Social Care Trust
Biography

After completing a PhD in Diabetes in The Queen’s University of Belfast, Jenny embarked on a career as a Clinical Scientist in Belfast Health and Social Care Trust. She was the Principal Clinical Scientist in the Regional Toxicology Laboratory from 2013-2021, before taking up her current position as a Consultant Clinical Scientist in Biochemistry and POCT in the Southern Health and Social Care Trust. Jenny is the current Chair of the Northern Ireland POCT Specialty Forum. She is also the STP training officer for Biochemistry in Northern Ireland, a member of the RCPath NI Council, and an associate editor for Labmed News. 


Job Title:
POCT Consultant Speciality lead, Chief Healthcare Scientist
Organisation
Berkshire and Surrey Pathology Services, Frimley Health Foundation Trust
Biography

Katy has been working in the NHS and its services for 20 years in Clinical Biochemistry and Point of Care Testing (POCT). Currently employed as the Consultant Specialty lead for POCT for Berkshire and Surrey Pathology Services, the service covers 5 NHS Trusts, with 6 acute medical sites and multiple community services. The service also provides a dedicated ISO accredited POCT EQA scheme, Qpoint of which Katy is the Clinical Director. At the end of 2020 Katy was seconded to the Department of Health and Social Care, then later UKHSA, Operational Supplies team as the Point of care workflow programme lead, with the primary aim of providing technical and scientific leadership in the deployment of rapid covid testing into NHS Emergency departments. In January 2024 Katy was made Chief Healthcare Scientist for Frimley Health NHS Foundation Trust with responsibility for executive representation of Healthcare science services at the Trust and into the ICS. 

Katy has worked alongside the national NHS England personalized care team to support the production of POCT guidance for Virtual ward and Hospital at Home services. The BSPS service provides Labkit to its partner Trusts and community Trusts, a roaming bag of POCT kit that can be used in multiple clinical services to support POCT testing for rapid decision making.


Job Title:
Lead BMS in POC and Rapid Testing
Organisation
Lancashire Teaching Hospitals NHS Foundation Trust
Biography

Lead BMS in POC and Rapid Testing since 2015

Technical Lead for Point of care for N3 region.

Member of the specialist panel for POCT for the IBMS.

Starting In the Microbiology laboratory in1996 as an MLA, Robert worked through the trainee route and started as a BMS in 2002. As an experienced member of staff who proactively involved himself in the modernisation of the department, Robert holds a great deal of knowledge both technical and clinical with regards to the equipment in use within the laboratory and has used this to both troubleshoot issues and train members of staff.

Robert took the role of Point of care coordinator in 2015. In 2019 The Rapid team was brought in alongside the POC service. Robert is part of a well-established friendly team, working within a modern, well equipped and connected POC team at Lancashire Teaching Hospitals NHS Foundation Trust.


Job Title:
Consultant Biochemist and Clinical Lead for POCT
Organisation
Stockport NHS Foundation Trust
Biography

Sharman is a Consultant Clinical Scientist and Clinical POCT Lead at the Stockport NHS Foundation Trust. She is also Clinical Chair of the Greater Manchester POCT subgroup contributing towards developing the POCT strategy for the network and a member of the North West POCT group.

Sharman worked at Betsi Cadwaladr University Health Board in North Wales, before joining the team at Stepping Hill Hospital in March 2021. Prior to this Sharman worked in the North West Region at the Royal Manchester Children’s Hospital Willink Unit after completing training at Hope Hospital in Salford.

Sharman was Chair of the then ACB (Association of Clinical Biochemistry and Laboratory Medicine) Wales region from 2019 to 2021 and was previously Secretary of the region from 2015. She was also Chair of the All Wales Clinical Biochemistry audit group and North Wales Clinical Biochemist Audit Lead. 

Her main interests include Point of Care Testing (POCT), in particular the development of POCT services closer to home and supporting antimicrobial stewardship. Her FRCPath dissertation involved development of a rural community POCT service. Recently she has been involved in setting up the North West and Greater Manchester Acute Respiratory Infection Hub, POCT pilot and POCT Pathology network group evaluation of genetic POCT with the Genedrive Analyser. 

Sharman has also maintained a keen interest in R&D throughout her career, initially in endocrinology at Hope Hospital in Salford. She represented Pathology on the Health Board Research and innovation committee, being Principal Investigator on a number of studies including for Covid-19 testing. Currently she is Pathology R&I Lead at Stockport FT.

Attendee feedback

Check out just some of the great feedback attendees shared from the day:

"Really useful to get an update on what is happening in POCT in the UK"

POCT National Networking Forum 2025, March 2025

"Very good. Excellent knowledge sharing"

POCT National Networking Forum 2025, March 2025

"Enjoyed networking and hearing peoples experience"

POCT National Networking Forum 2025, March 2025

"Excellent networking event with POCT teams across UK and POCT companies"

POCT National Networking Forum 2025, March 2025

"Really inspiring to get together"

POCT National Networking Forum 2025, March 2025

"Useful tips and experiences of industry experts"

POCT National Networking Forum 2025, March 2025

"Very well-run day. Great talks with lots of useful information and knowledge sharing"

POCT National Networking Forum 2025, March 2025

"Valuable experience listening to how POCT services in other areas/countries are delivered and managed"

POCT National Networking Forum 2025, March 2025

"Very informative, engaging and interesting speakers. Lovely venue and good to have interactive discussions"

POCT National Networking Forum 2025, March 2025

"It was very informative and really good to be able to share learning. Thank you so much!"

POCT National Networking Forum 2025, March 2025

"Excellent network event with extremely useful updates in POCT"

POCT National Networking Forum 2025, March 2025

"Fantastic agenda, relevant and pertinent"

POCT National Networking Forum 2025, March 2025

Past attendee feedback

Last held in 2024 in Birmingham on Wednesday 24th April 2024 at the Birmingham City Football Club, this vital face-to-face networking event was described as:

“Excellent! Always open and full of new friends, a supportive community in POCT. Excellently managed day and delivered well and to time”

Cambridge University Hospitals NHS Foundation Trust

“Very informative and great opportunity to meet people working in the same field and sharing our thoughts”

South West London Pathology

“Very thought-provoking and being able to see variation in the maturity of POCT throughout the UK very useful”

University Hospitals of Derby and Burton NHS

“Good, well-organised meeting. Particularly enjoyed the opportunities to discuss topics at a table”

Birmingham Quality UK NEQAS

“Good content covering issues with the development of POCT – but really good to see other Trusts also having same issues knowing we can work together”

University Hospitals Birmingham NHS Foundation Trust

“Really inspiring and informative – far exceeded my expectations”

University Hospitals Sussex NHS Foundation Trust

View further comments on SBK Healthcare events on Trust Pilot.

With thanks to our sponsors


    

Abbott is a global leader in in-vitro diagnostics with one of the broadest portfolios of businesses spanning nearly every segment - point of care, immunoassay, clinical chemistry, haematology, blood screening, molecular and informatics. Abbott's life-changing tests and diagnostic tools provide accurate, timely information to better manage health. We're empowering smarter medical and economic decision making to help transform the way people manage their health at all stages of life.


BHR BIOSYNEX is a market leading company in point-of-care healthcare diagnostics, enabling appropriate tests to be moved closer from the lab to the patient, to better manage and treat conditions.


Fujifilm Healthcare UK’s DRI-CHEM IVD portfolio delivers fast, accurate results. Designed for efficiency, it empowers clinicians to make quicker, informed decisions, ensuring patients aren’t delayed. Our solutions are designed to bring the lab to you, because every moment matters.


 

Genedrive Diagnostics Ltd is a pharmacogenetic testing company developing and commercialising a rapid and simple to use point of need pharmacogenetic platform for the diagnosis of genetic variants. Thus, enabling healthcare professionals to provide accessible, personalised treatment to the right patient at the right time.


   

Roche is the UK’s leading provider of in vitro diagnostics tests and in 2022 more than 752 million Roche diagnostic tests were used by clinicians across the UK to confirm, rule out or manage health conditions including cancer, heart disease, diabetes, sepsis, human papillomavirus (HPV) and many others.


   

Abbott is a global leader in point-of-care (POC) diagnostics with a comprehensive portfolio of rapid tests, services, and handheld devices for use in a wide variety of healthcare settings: labs, clinics, remote healthcare outposts, retail outlets, the patient’s bedside and at home. Abbott’s offering of near-patient tests and services spans key health and therapeutic areas, including infectious disease, cardiometabolic, informatics, toxicology and consumer diagnostics.


With thanks to our exhibitors

           

Why sponsor this SBK Healthcare Forum

Our role at SBK Healthcare is to bring industry together with healthcare professionals so that you can educate and inform your audience. These trail-blazing forums offer dedicated presentations, Q&A, networking and discussion time, each sponsor will be fully immersed into the event and able to effectively engage with your NHS audience.

"BHR Biosynex was delighted to sponsor the POCT National Networking Forum 2025. The event was exceptionally well-organised, providing fantastic branding opportunities for us. The agenda and speaker lineup were highly engaging, and the quality of delegates was excellent. We particularly appreciated the effort and care taken to encourage delegates to visit the exhibitor stands, fostering valuable interactions. It was a great opportunity to connect with key stakeholders in point-of-care testing, and we look forward to future collaborations"

BHR Biosynex, POCT National Networking Forum, March 2025

"The event was extremely well organised and run. From an exhibitor standpoint, the way we were able to speak to so many of the delegates was invaluable"

Sterilab, POCT National Networking Forum, March 2025

Interested in having your own event, managed by us?

SBK Healthcare also provides in-house forums. Working closely with you as the client we can research, produce, market and deliver the conference or online forum that best suits the audience and meets your goals.

Reach out today

If you would like more information on our sponsorship options an in-house forum or if you wish to discuss your needs and what solutions may be appropriate for your business, please contact: 

Sarah Kemm 

Contact: 01732 897788 

Email: sarah.kemm@sbk-healthcare.co.uk

Thank you for attending an event by SBK Healthcare. We are pleased to offer you on-line access to the documentation that you received at the event. This is an exclusive benefit for all of the attendees and includes additional and updated documentation.